Search results for Anti-CD8

APC Anti-CD8 antibody [MEM-31], Abcam, AB26004

The purified antibody is conjugated with cross-linked Allophycocyanin (APC) under optimum conditions.

FITC Anti-CD8 alpha antibody [2.43], Abcam, AB210214

The purified antibody was conjugated under optimal conditions, with unreacted dye removed from the preparation.

FITC Anti-CD8 alpha antibody [EP72], Abcam, AB24899

FITC Anti-CD8 alpha antibody [EPR21769], Abcam, AB237367

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

FITC Anti-CD8 alpha antibody [HIT8a], Abcam, AB95591

FITC Anti-CD8 alpha antibody [KT15], Abcam, AB22504

Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC) FITC : Protein (molar ratio) = 5.3 : 1.0

FITC Anti-CD8 alpha antibody [OKT8], Abcam, AB210326

This antibody is widely used as a phenotypic marker for CD8 alpha on cytotoxic T cells, thymocytes, as well as on certain cell types that do not also express the TCR, including some NK cells and lymphoid dendritic cells.

FITC Anti-CD8 alpha antibody [SK1], Abcam, AB210367

The purified antibody was conjugated under optimal conditions, with unreacted dye removed from the preparation. This antibody is widely used as a phenotypic marker for CD8 alpha on cytotoxic T cells, thymocytes, as well as on certain cell types that do not also express the TCR, including some NK cells and lymphoid dendritic cells.

FITC Anti-CD8 beta antibody [341], Abcam, AB95527

Excitation: 488 nm Emission: 518 nm.

Biotin Anti-CD8 alpha antibody [53-6.7], Abcam, AB25176

In vivo and in vitro treatment with ab25176 effectively depletes CD8 alpha+ cells. ab25176 also blocks allogeneic help specific for class I MHC antigens and T cell responses to IL-2.